Antithrombin-binding oligosaccharides: structural diversities in a unique function? - Wikidata - awgldk - TriplyDB

Antithrombin-binding oligosaccharides: structural diversities in a unique function?

Antithrombin-binding oligosaccharides: structural diversities in a unique function?

http://www.wikidata.org/entity/Q38304819

about

Heparan sulfate and heparin interactions with proteins Uncovering the Relationship between Sulphation Patterns and Conformation of Iduronic Acid in Heparan Sulphate Marine organism sulfated polysaccharides exhibiting significant antimalarial activity and inhibition of red blood cell invasion by Plasmodium Insights into the role of 3-O-sulfotransferase in heparan sulfate biosynthesis.New Insights in Thrombin Inhibition Structure-Activity Relationships by Characterization of Octadecasaccharides from Low Molecular Weight Heparin.Heparin: new life for an old drug.Synthesis of 3-O-Sulfated Oligosaccharides to Understand the Relationship between Structures and Functions of Heparan Sulfate.Analysis of Heparins Derived From Bovine Tissues and Comparison to Porcine Intestinal Heparins.Replacement of the L-iduronic acid unit of the anticoagulant pentasaccharide idraparinux by a 6-deoxy-L-talopyranose - Synthesis and conformational analysis

P2860

Q26796383-86822956-3F81-4DF6-A411-31FB5C3713F9 Q27329880-B9D33688-F502-4E4D-8312-8378087DCE19 Q36793205-227E391F-ADF1-42DA-B4D1-D1FE87266E97 Q38287587-E94B3737-89D5-48D8-AB58-1EDF20E0F186 Q38288742-54BED94A-7780-45C4-8BA8-9DC0E97C20B6 Q40164066-5E721BD2-033B-415A-9D18-950833CB6179 Q48364205-46109FD8-3B57-48B9-B6DA-C7AE37EE3F83 Q51369361-5D3FE4D3-43BE-4F6A-B8E5-C9CDAE66AE47 Q58743814-AB07AF0F-C258-4B56-A050-6ED5137FBC11

P2860

Antithrombin-binding oligosaccharides: structural diversities in a unique function?

http://www.wikidata.org/entity/Q38304819

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Antithrombin-binding oligosaccharides: structural diversities in a unique function?

@en

type

label

Antithrombin-binding oligosaccharides: structural diversities in a unique function?

@en

prefLabel

Antithrombin-binding oligosaccharides: structural diversities in a unique function?

@en

P1433

Q38304819-3600674E-D29B-4ED2-B558-EA80F20900A2

P1476

Q38304819-430489F4-2ECF-42E5-9FC1-AAC73F3BE800

P2093

Q38304819-298C47B9-D318-43D4-A4D9-D82D7FFD4D28

Q38304819-55FD7C75-C919-46D7-9903-E8E7A2BBE485

Q38304819-EBAC9834-F8C9-4C4C-AA1A-B1F488C03F69

P2860

Q38304819-02BB6A63-45BB-48B1-B7CA-7B00BAC55EC8

Q38304819-0E646DBA-10E1-4FB0-9BC8-80CDCB21B136

Q38304819-2C9F4BCF-D3E5-4E4D-8C74-C819932D1F40

Q38304819-2E2A688A-0C97-4164-9769-673DCDCBEC22

Q38304819-35FC7E21-04C9-443C-98D9-700914EAFB1A

Q38304819-3A67C2B5-1AFD-477E-BBDA-2D733ACC0013

Q38304819-4467F077-0110-4A8C-B41F-7D8BD4EBE292

Q38304819-4DD0A8E8-BE62-4C78-8A72-A1B38BFB151E

Q38304819-4E0E235E-8FFA-49AA-88BA-ACFBA9556B73

Q38304819-521B89D5-18AB-42F6-AE06-ECEFCA3BEA85

P2888

Q38304819-A032F57A-004B-4C3F-9E3F-F2E0C609E97B

P304

Q38304819-0C02EC77-EE7F-4BFC-B9CA-2CDE0D80F8B9

P31

Q38304819-573E95A4-100B-49F3-A6FC-37E22A91B1E6

P356

Q38304819-FA5C38B3-5BF7-4E99-9255-59CAAA55012C

P433

Q38304819-ADE0E53A-2B3D-48EE-B637-139F211BF36A

P478

Q38304819-A3057A1D-EE27-47A4-B033-832C1DC8ED91

P50

Q38304819-CDC277E1-C755-42D9-B494-3421FCDA6C54

P577

Q38304819-E0424768-B8C1-44C7-92A5-47D9DCA75555

P5875

Q38304819-69DE073D-B0BC-44F8-AB6C-3CEEF32D698E

P6179

Q38304819-E73F2A76-4826-4C86-97F1-BDBD7AB57930

P698

Q38304819-5D3181CF-61B5-45F8-BEFB-A47A0F828202

P921

Q38304819-6C25C2B1-3FD5-450E-9793-3F354F841525

P356

S10719-014-9543-9

P1433

Glycoconjugate Journal

P1476

Antithrombin-binding oligosaccharides: structural diversities in a unique function?

@en

P2093

Christian Viskov

http://www.w3.org/2001/XMLSchema#string

Giangiacomo Torri

http://www.w3.org/2001/XMLSchema#string

Pierre A J Mourier

http://www.w3.org/2001/XMLSchema#string

P2860

N.m.r. and molecular-modelling studies of the solution conformation of heparin

Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation

The anticoagulant activation of antithrombin by heparin

Structure of beta-antithrombin and the effect of glycosylation on antithrombin's heparin affinity and activity

Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparin

Structure of a heparin-linked biologically active dimer of fibroblast growth factor

A unique trisaccharide sequence in heparin mediates the early step of antithrombin III activation

Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures.

A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?

Chemoenzymatic synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities.

P2888

s10719-014-9543-9

P304

409-416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10719-014-9543-9

http://www.w3.org/2001/XMLSchema#string

P433

6-7

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264990532

http://www.w3.org/2001/XMLSchema#string

P6179

1028585935

http://www.w3.org/2001/XMLSchema#string

P698

25145542

http://www.w3.org/2001/XMLSchema#string

P921

oligosaccharide